The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-bromo-N-((R)-1-((R)-3-(4-(2-cyanophenyl)piperazin-1-yl)-2-hydroxypropoxy)-3-phenylpropan-2-yl)benzenesulfonamide ID: ALA5283504
Max Phase: Preclinical
Molecular Formula: C29H33BrN4O4S
Molecular Weight: 613.58
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccccc1N1CCN(C[C@@H](O)COC[C@@H](Cc2ccccc2)NS(=O)(=O)c2ccc(Br)cc2)CC1
Standard InChI: InChI=1S/C29H33BrN4O4S/c30-25-10-12-28(13-11-25)39(36,37)32-26(18-23-6-2-1-3-7-23)21-38-22-27(35)20-33-14-16-34(17-15-33)29-9-5-4-8-24(29)19-31/h1-13,26-27,32,35H,14-18,20-22H2/t26-,27-/m1/s1
Standard InChI Key: QSUSOTUHCHGTAN-KAYWLYCHSA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
-1.1930 1.3979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7743 0.8124 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.9767 0.6017 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.3341 2.0332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3353 1.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6230 0.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9090 1.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9119 2.0368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6247 2.4445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2014 2.4506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4878 2.0421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7775 2.4560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0640 2.0476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3536 2.4613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3598 2.0530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0703 2.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3629 1.2306 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7839 2.0581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7806 1.2349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4900 0.8267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2028 1.2369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2017 2.0600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4876 2.4728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9126 0.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9112 0.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6223 -0.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3353 0.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3326 0.8323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6209 1.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4848 1.2201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7682 -0.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4813 -0.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4785 -1.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7645 -1.6507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0517 -1.2325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0580 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7603 -2.4728 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
3.2020 -0.4029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4895 -0.8133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
15 17 1 1
16 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
18 23 1 0
22 23 1 0
21 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
11 30 1 6
30 2 1 0
2 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
34 37 1 0
25 38 1 0
38 39 3 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 613.58Molecular Weight (Monoisotopic): 612.1406AlogP: 3.41#Rotatable Bonds: 12Polar Surface Area: 105.90Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.61CX Basic pKa: 7.47CX LogP: 4.58CX LogD: 4.24Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.32Np Likeness Score: -1.31
References 1. Huang H, Zhang Y, Xu X, Liu Y, Zhao J, Ma L, Lei J, Ge W, Li N, Ma E, Li Y, Yuan L.. (2023) Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells., 80 [PMID:36427655 ] [10.1016/j.bmcl.2022.129087 ]